Blogg

  • Reset
2.11.22 | Health Equity
SWHR’s Chief Science Officer on Her Path in Science 

SWHR Chief Science Officer Irene Aninye, PhD, share her path to and through science as part of International Day of Women and Girls in Science on February 11.

Jill Becker 2.8.22 | Research and Clinical Trials
Dr. Jill Becker Builds a Vision for the Future of Biology of Sex Differences 

Dr. Jill Becker, editor-in-chief at Biology of Sex Differences (BSD), shared her journey through science research and her work to drive women’s health research forward.

11.8.21 | Health Equity
Disparities in Biomedical Research: A Women’s Health Issue

This blog summarizes the state of disparities in biomedical research and how they might be addressed.

7.20.21 | Policy
SWHR Comments to NCI on Enhancing Diversity and Inclusion

4.8.21 | Policy
SWHR Comments to NIH UNITE Initiative Committees on Diversity in Biomedical Careers

4.7.21 | Research and Clinical Trials
Panel: Improving Diversity in Clinical Trials Better Serves Patients

Researchers and health care stakeholders must actively pursue more representative clinical trials and make changes that encourage the participation of historically marginalized groups within the research community.

3.23.21 | Policy
Position Statement: Advancement of Women in the Biomedical Workforce

An Official Position Statement of the Society for Women’s Health Research POSITION Science benefits from diversity. Individuals of all genders, […]

3.23.21 | Health Equity
Position Statement: Improving Women’s Health Equity

An Official Position Statement of the Society for Women’s Health Research POSITION Sex and gender, race and ethnicity, identity, faith, […]

3.9.21 | Research and Clinical Trials
People of Color Continue to Be Underrepresented in Research on New Drugs

After decades of being underrepresented in biomedical research, women have accounted for more than 50% of participants in clinical trials for FDA-approved new drugs in the past four years.

3.4.21 | Health Equity
Harnessing the Power of AI for All Patients Requires Focus on Equity and Transparency

It is imperative that AI developers and regulators consider race, ethnicity, and gender in their datasets to work toward improved health equity for women and people of color.